The Motley Fool's incorrect reporting may promote some buying this afternoon... lol:Neuren Pharmaceuticals Ltd (ASX: NEU)
Neuren Pharmaceuticals is our first All Ords share to check out. Neuren is having a pretty fabulous day. The company is presently up a decent 1.64% at $8.67 a share.
But this morning, Neuren shares spiked as high as $8.80 each. That is not only a new 52-week high for the Neuren Pharmaceuticals share price, but the highest Neuren has traded since way back in early 2007.
Yes, Neuren is trading at a post-GFC high today. Neuren shares are now up more than 120% year to date. It’s not hard to see why.
In a quarterly update last month, Neuren announced a new drug has been approved by the US Food and Drug Administration (FDA). The company is anticipating revenue from this new drug alone of $112 million in 2023.
The Motley Fool's incorrect reporting may promote some buying...
-
- There are more pages in this discussion • 8,181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.620(2.99%) |
Mkt cap ! $2.569B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $19.92 | $5.947M | 296.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $20.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.19 | 10 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |